Physician Assistant Program year 2025 Reported 2023–2025 Source: CMS Open Payments, 2026 publication

Keri Wehling

Physician Assistant Augusta, KS Physician Assistant

NPI 1053426114 CMS profile 274247

1306 State St, Augusta, KS 67010

Open in the dashboard

General payments

$672

25 records reported · program years 2023–2025

Research payments

$0

Paid to them · None reported · program years 2023–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Keri Wehling of Augusta, KS is reported in the CMS Open Payments database as having received $672 across 25 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 61st percentile of Physician Assistant profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

3 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $139 8
2024 General $326 12
2023 General $208 5

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Keri Wehling
  • Physician Assistant median
  • Middle half of Physician Assistant
  • National median

In program year 2025, general payments to Keri Wehling were reported at $139. Among 68,903 Physician Assistant profiles paid that year, the median was $184 and the middle half received between $57 and $620.

Show as a table
Year Keri Wehling Physician Assistant median Middle half National median
2019 $0 $34 $17–$122 $163
2020 $0 $33 $16–$78 $114
2021 $0 $132 $37–$438 $132
2022 $0 $155 $48–$522 $149
2023 $208 $167 $52–$557 $160
2024 $326 $178 $55–$600 $164
2025 $139 $184 $57–$620 $169

Breakdown

Who paid General payments · program years 2023–2025
  1. Kerecis Limited $262 4 payments
  2. Smith+Nephew, Inc. $108 6 payments
  3. Organogenesis Inc. $81 3 payments
  4. AbbVie, Inc. $41 3 payments
  5. Next Science LLC $41 1 payment
  6. Paratek Pharmaceuticals, Inc. $39 2 payments
  7. Solventum Corporation $32 2 payments
  8. Coloplast Corp $23 1 payment
  9. BSN Medical Inc $18 1 payment
  10. MIMEDX Group, Inc. $16 1 payment
  11. Other $11 1 payment

Every payment, record by record

What the payments were for General payments · program years 2023–2025
  1. Food and Beverage $672 25 payments
Products named General payments · program years 2023–2025
  1. Kerecis Omega3 SurgiClose Wound Care $262 4 payments
  2. Kerecis Omega3 GraftGuide $170 2 payments
  3. Kerecis Omega3 SurgiClose Wound Care $149 1 payment
  4. Kerecis Omega3 Marigen Wound Care $149 1 payment
  5. Kerecis Omega3 SurgiClose Wound Care $149 1 payment
  6. Kerecis Omega3 Marigen Wound Care $112 3 payments
  7. Kerecis Omega3 Marigen Wound Care $92 2 payments
  8. Kerecis Omega3 Marigen Wound Care $92 2 payments
  9. Kerecis Omega3 Marigen Wound Care $92 2 payments
  10. DALVANCE $41 3 payments
  11. Other $452 20 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 5 drugs

Part D claims

86

Median for Physician Assistant: 241

Drug cost

$2,584

Median for Physician Assistant: $4,110

Branded share of claims

51.2%

Median for Physician Assistant: 19.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Gentamicin Sulfate Generic 13 $1,718
Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav Brand 15 $315
Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim Brand 29 $230
Cephalexin Generic 14 $172
Ciprofloxacin Hcl Generic 15 $149

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 114,276 Part D prescribers listed as Physician Assistant; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 59 billing codes

Paid by Medicare

$1,638,616

Of which drugs: $1,184,829

Medicare patients

280

Average age 73

Services billed

5,681

133 women, 147 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 56%
Diabetes 55%
Ischemic heart disease 55%
Chronic kidney disease 50%
Heart failure 47%
Depression 47%
Atrial fibrillation 45%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Membrane graft or membrane wrap, per square centimeter Q4205 Office 23 382 $401,784
Epieffect, per square centimeter Q4278 Office 17 549 $162,461
Puraply xt, per square centimeter Q4197 Office 13 825 $62,601

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

1 product · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
NUZYRA
  • Paratek Pharmaceuticals, Inc. $21
$21 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

Records

25 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Physician Assistant in Kansas

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record